La Jolla Pharmaceutical Company

NCT06487585

Collaborator, Phase 4, Recruiting, 2025, 100 people, 5 Jul 2024, clinicaltrials.gov

NCT05824767

Collaborator, Phase 4, Completed, 2023, 42 people, 24 Apr 2023, clinicaltrials.gov

NCT05193370

Collaborator, Phase 4, Withdrawn, 2022, 0 people, 14 Jan 2022, clinicaltrials.gov

NCT04904562

Collaborator, Phase 4, Terminated, 2022, 2 people, 27 May 2021, clinicaltrials.gov

NCT04901169

Collaborator, Phase 2/3, Active, not recruiting, 2022, 50 people, 25 May 2021, clinicaltrials.gov

NCT04529005

Collaborator, Phase 4, Completed, 2020, 20 people, 27 Aug 2020, clinicaltrials.gov

NCT03623529

Phase 2, Status unknown, 2018, 100 people, 9 Aug 2018, clinicaltrials.gov

NCT03431077

Phase 2, Completed, 2018, 2 people, 13 Feb 2018, clinicaltrials.gov

NCT02338843

Phase 3, Completed, 2015, 344 people, 14 Jan 2015, clinicaltrials.gov

NCT00776802

Phase 1/2, Withdrawn, 2008, 0 people, 21 Oct 2008, clinicaltrials.gov

NCT00609817

Phase 1, Terminated, 2008, 9 people, 7 Feb 2008, clinicaltrials.gov